Johnson & Johnson subsidiary acquisition of lung disease drug manufacturers Respivertrt

2010-06-08

   Johnson & Johnson's Centocorntho Biotechnology Company announced yesterday，The acquisition of respivert pharmaceutical has been completed。The latter is a main R & D and use of small molecules、Pharmaceutical Company that inhale therapy to treat lung disease。      Through this acquisition，Centocorortho Biotechnology Company will get small molecules for severe lung diseases，Advanced technology of inhaling therapy。No disclosure of the transaction for both parties，But Centoco ...